Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans

Fabienne Benz, Sarah Camara-Wilpert, Jakob Russel, Katharina G. Wandera, Rimvydė Čepaitė, Manuel Ares-Arroyo, José Vicente Gomes-Filho, Frank Englert, Johannes A. Kuehn, Silvana Gloor, Mario Rodríguez Mestre, Aline Cuénod, Mònica Aguilà-Sans, Lorrie Maccario, Adrian Egli, Lennart Randau, Patrick Pausch, Eduardo P.C. Rocha, Chase L. Beisel, Jonas Stenløkke MadsenDavid Bikard, Alex R. Hall, Søren Johannes Sørensen*, Rafael Pinilla-Redondo*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

17 Citations (Scopus)

Abstract

Plasmid-encoded type IV-A CRISPR-Cas systems lack an acquisition module, feature a DinG helicase instead of a nuclease, and form ribonucleoprotein complexes of unknown biological functions. Type IV-A3 systems are carried by conjugative plasmids that often harbor antibiotic-resistance genes and their CRISPR array contents suggest a role in mediating inter-plasmid conflicts, but this function remains unexplored. Here, we demonstrate that a plasmid-encoded type IV-A3 system co-opts the type I-E adaptation machinery from its host, Klebsiella pneumoniae (K. pneumoniae), to update its CRISPR array. Furthermore, we reveal that robust interference of conjugative plasmids and phages is elicited through CRISPR RNA-dependent transcriptional repression. By silencing plasmid core functions, type IV-A3 impacts the horizontal transfer and stability of targeted plasmids, supporting its role in plasmid competition. Our findings shed light on the mechanisms and ecological function of type IV-A3 systems and demonstrate their practical efficacy for countering antibiotic resistance in clinically relevant strains.

Original languageEnglish
JournalCell Host and Microbe
Volume32
Issue number6
Pages (from-to)875-886.e9
Number of pages12
ISSN1931-3128
DOIs
Publication statusPublished - 2024

Bibliographical note

Publisher Copyright:
© 2024 Elsevier Inc.

Keywords

  • adaptive immunity
  • antibiotic resistance
  • CRISPR-Cas
  • DinG helicase
  • inter-plasmid competition
  • Klebsiella pneumoniae
  • phages
  • plasmids
  • type IV CRISPR-Cas

Cite this